HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
October 31 2024 - 8:31AM
Business Wire
HeartBeam, Inc. (NASDAQ: BEAT), a medical technology
company focused on transforming cardiac care by providing powerful
cardiac insights wherever the patient is, will hold a conference
call on Thursday, November 7, 2024 at 4:30 p.m. Eastern time to
discuss its results for the third quarter ended September 30, 2024,
and will be providing regulatory updates, reviewing ongoing
initiatives, and anticipated milestones. A press release detailing
these results will be issued prior to the call.
HeartBeam CEO Robert Eno, Founder and President Branislav
Vajdic, PhD, and CFO Timothy Cruickshank will host the conference
call, followed by a question-and-answer period. The conference call
will be accompanied by a presentation, which can be viewed during
the webcast or accessed via the investor relations section of the
Company’s website here.
To access the call, please use the following information:
Date:
Thursday, November 7, 2024
Time:
4:30 p.m. Eastern time (1:30 p.m. Pacific
time)
Dial-in:
1-800-717-1738
International Dial-in:
1-646-307-1865
Conference Code:
1101650
Webcast:
https://viavid.webcasts.com/starthere.jsp?ei=1692718&tp_key=af2e025952
A telephone replay will be available approximately three hours
after the call and will run through February 7, 2025, by dialing
1-844-512-2921 from the U.S., or 1-412-317-6671 from international
locations, and entering replay pin number: 1101650. The replay can
also be viewed through the webcast link above and the presentation
utilized during the call will be available in the company’s
investor relations section here.
About HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company
dedicated to transforming cardiac care by providing powerful
cardiac insights wherever the patient is. The Company is creating
the first ever cable-free 12-lead ECG capable of capturing the
heart’s electrical signals from three dimensions. This platform
technology is designed to be used in portable devices that can be
used wherever the patient is to deliver actionable heart
intelligence. Physicians will be able to identify cardiac health
trends and acute conditions and direct patients to the appropriate
care – all outside of a medical facility, thus redefining the
future of cardiac health management. The Company holds 13 US and 4
international issued patents related to technology enablement.
For additional information, visit HeartBeam.com.
Forward-Looking Statements
All statements in this release that are not based on historical
fact are "forward-looking statements." While management has based
any forward-looking statements included in this release on its
current expectations, the information on which such expectations
were based may change. Forward-looking statements involve inherent
risks and uncertainties which could cause actual results to differ
materially from those in the forward-looking statements, as a
result of various factors including those risks and uncertainties
described in the Risk Factors and in Management’s Discussion and
Analysis of Financial Condition and Results of Operations sections
of our Forms 10-K, 10-Q and other reports filed with the SEC and
available at www.sec.gov. We urge you to consider those risks and
uncertainties in evaluating our forward-looking statements. We
caution readers not to place undue reliance upon any such
forward-looking statements, which speak only as of the date made.
Except as otherwise required by the federal securities laws, we
disclaim any obligation or undertaking to publicly release any
updates or revisions to any forward-looking statement contained
herein (or elsewhere) to reflect any change in our expectations
with regard thereto or any change in events, conditions or
circumstances on which any such statement is based.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241031901192/en/
Investor Relations Contact: Chris Tyson Executive Vice
President MZ North America Direct: 949-491-8235 BEAT@mzgroup.us
www.mzgroup.us
Media Contact:media@heartbeam.com
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Nov 2024 to Dec 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Dec 2023 to Dec 2024